FindTrial
Sign In

Comparison of advanced techniques of radiotherapy with standard techniques for left breast radiotherapy

Dosimetric comparison of Hybrid-VMAT with 3DCRT and VMAT in adjuvant radiotherapy for left breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035673
Enrollment
79
Registered
2021-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Nil: Nil (only dosimetric study, with execution of the superior treatment plan for the patient)

Sponsors

Manipal College of Health Professions
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Left breast cancer patients undergoing adjuvant external beam radiotherapy to the breast/ chest wall and regional nodes.

Exclusion criteria

Exclusion criteria: 1)Patients requiring palliative RT. 2)Patients planned for treatment with accelerated partial breast irradiation (APBI). 3)Patients requiring adjuvant RT to bilateral breasts. 4)Patients with connective tissue disorders, prior irradiation, and other comorbidities that might affect the outcomes of breast radiotherapy. 5)Unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frame
1) Dosimetric parameters for target and Organs at Risk. 2)Time taken for planning 3)Out-of field scatter dose Timepoint: 8 weeks—

Secondary

MeasureTime frame
Recordings of acute side effects.Timepoint: 3 months after completion of treatment—

Countries

India

Contacts

Public ContactDr Krishna Sharan

Manipal College of Health Professions

shambhavi.c@manipal.edu9901437794

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026